Per Stirling Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.8M | Buy |
9,682
+60
| +0.6% | +$11.1K | 0.23% | 77 |
|
|
2025
Q1 | $2.02M | Buy |
9,622
+56
| +0.6% | +$11.7K | 0.29% | 75 |
|
|
2024
Q4 | $1.7M | Sell |
9,566
-340
| -3% | -$60.4K | 0.24% | 77 |
|
|
2024
Q3 | $1.96M | Buy |
9,906
+3
| +0% | +$592 | 0.27% | 69 |
|
|
2024
Q2 | $1.7M | Buy |
9,903
+5,534
| +127% | +$949K | 0.27% | 68 |
|
|
2024
Q1 | $796K | Buy |
4,369
+245
| +6% | +$44.6K | 0.13% | 104 |
|
|
2023
Q4 | $639K | Buy |
4,124
+7
| +0.2% | +$1.09K | 0.12% | 108 |
|
|
2023
Q3 | $614K | Buy |
4,117
+100
| +2% | +$14.9K | 0.13% | 102 |
|
|
2023
Q2 | $541K | Sell |
4,017
-447
| -10% | -$60.2K | 0.11% | 114 |
|
|
2023
Q1 | $711K | Sell |
4,464
-470
| -10% | -$74.9K | 0.15% | 85 |
|
|
2022
Q4 | $797K | Buy |
+4,934
| New | +$797K | 0.15% | 91 |
|